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abstract
 
The cystic ﬁbrosis transmembrane conductance regulator (CFTR) is a phosphorylation- and ATP-
dependent chloride channel that modulates salt and water transport across lung and gut epithelia. The relationship
between CFTR and oxidized forms of glutathione is of potential interest because reactive glutathione species are
produced in inﬂamed epithelia where they may be modulators or substrates of CFTR. Here we show that CFTR
channel activity in excised membrane patches is markedly inhibited by several oxidized forms of glutathione (i.e.,
GSSG, GSNO, and glutathione treated with diamide, a strong thiol oxidizer). Three lines of evidence indicate that
the likely mechanism for this inhibitory effect is glutathionylation of a CFTR cysteine (i.e., formation of a mixed
disulﬁde with glutathione): (a) channels could be protected from inhibition by pretreating the patch with NEM
(a thiol alkylating agent) or by lowering the bath pH; (b) inhibited channels could be rescued by reducing agents
(e.g., DTT) or by puriﬁed glutaredoxins (Grxs; thiol disulﬁde oxidoreductases) including a mutant Grx that
speciﬁcally reduces mixed disulﬁdes between glutathione and cysteines within proteins; and (c) reversible
glutathionylation of CFTR polypeptides in microsomes could be detected biochemically under the same conditions.
At the single channel level, the primary effect of reactive glutathione species was to markedly inhibit the opening
rates of individual CFTR channels. CFTR channel inhibition was not obviously dependent on phosphorylation
state but was markedly slowed when channels were ﬁrst “locked open” by a poorly hydrolyzable ATP analogue
(AMP-PNP). Consistent with the latter ﬁnding, we show that the major site of inhibition is cys-1344, a poorly
conserved cysteine that lies proximal to the signature sequence in the second nucleotide binding domain (NBD2)
of human CFTR. This region is predicted to participate in ATP-dependent channel opening and to be occluded in
the nucleotide-bound state of the channel based on structural comparisons to related ATP binding cassette
transporters. Our results demonstrate that human CFTR channels are reversibly inhibited by reactive glutathione
species, and support an important role of the region proximal to the NBD2 signature sequence in ATP-dependent
channel opening.
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INTRODUCTION
 
The cystic ﬁbrosis transmembrane conductance regula-
tor (CFTR) is a phosphorylation- and ATP-dependent
chloride channel that controls salt and water transport
across epithelial tissues (for reviews see Gadsby and
Nairn, 1999; Sheppard and Welsh, 1999). The CFTR
channel is essential for normal lung and gut physiology
in humans (Welsh and Smith, 1993; Gabriel et al.,
1994). CFTR belongs to the large family of ATP binding
cassette (ABC) transporters on the basis of its two cyto-
plasmic nucleotide binding domains (NBDs) and two
membrane spanning domains (Riordan et al., 1989).
The NBDs bind MgATP and promote channel opening
provided that sites within the centrally positioned
regulatory (R) domain are phosphorylated (typically
by cAMP-dependent protein kinase; Gadsby and Nairn,
1999). The major elements within the NBDs that medi-
ate ATP binding include the Walker A and B motifs
and the signature sequences, which are well conserved
among ABC transporters (Higgins, 1992). Both CFTR
NBDs participate in ATP-dependent channel gating; a
conclusion that is supported by a large number of
studies of CFTR NBD mutants (Gregory et al., 1991;
Carson et al., 1995; Gunderson and Kopito, 1995;
Cotton and Welsh, 1998). How the Walker motifs
and signature sequences within the two NBDs work
together to bind MgATP and to signal pore opening at
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the transmembrane domains is unclear. Current mod-
els of CFTR channel gating (e.g., Berger et al., 2002;
Vergani et al., 2003) are based in large part on struc-
tural information from bacterial ABC transporters such
as the 
 
Escherichia coli
 
 vitamin B
 
12
 
 and maltose transport-
ers and from the crystal structure of Rad50, a related
ATPase (Hopfner et al., 2000; Locher et al., 2002; Chen
et al., 2003). The NBDs within these proteins dimerize
to form two composite ATP binding sites. Residues
from the Walker A motifs and signature sequences of
the opposing NBDs line each ATP binding pocket in
the crystal structures of Rad50 and the NBD dimer of
the maltose transporter (Hopfner et al., 2000; Chen et
al., 2003). Whether the two CFTR NBDs also associate
to form composite ATP binding sites, and how nucle-
otide binding subsequently promotes CFTR channel
opening, are unresolved issues.
CFTR channels potentially can be modulated by oxi-
dants in addition to the more well-studied physiologic
activators (e.g., PKA and ATP). The CFTR polypeptide
possesses 18 cysteine residues that are possible targets
for oxidation, many of which reside in the NBDs and
R domain. Identifying reactive species that modulate
CFTR channel activity and mapping the target cysteines
could provide insights into the structural basis of CFTR
gating. In addition, if CFTR channels are regulated sub-
stantially by reactive species, such regulation may have
pathophysiologic signiﬁcance since the lung and gut are
rich in oxidants under inﬂammatory conditions such as
asthma and colitis (Montuschi and Barnes, 2002; Pavlick
et al., 2002). Harrington et al. (1999) ﬁrst reported that
several conventional thiol oxidizers (e.g., KMnO
 
4
 
 and
NO) can affect the dynamics of CFTR channel gating
in synthetic lipid bilayers and excised inside-out mem-
brane patches. The oxidizers that were tested in these
initial studies had interesting effects on gating kinetics
(i.e., they slowed both the open and close rates), but ap-
peared to have only modest effects on net channel activ-
ity (i.e., single channel open probability).
We were intrigued by the possibility that CFTR chan-
nels might be regulated more substantially by oxi-
dized forms of glutathione for several reasons. First, glu-
tathione is abundant within cells (i.e., millimolar con-
centrations), and can be oxidized by a variety of reactive
oxygen and nitrogen species and other thiol-modify-
ing reagents in vitro and in vivo (Thomas et al., 1995;
Pompella et al., 2003; Schrammel et al., 2003). In turn,
oxidized forms of glutathione (i.e., glutathione disulﬁde
S-oxide, GS(O)SG, nitrosylated glutathione, GSNO, and
glutathione disulﬁde, GSSG) can promote the forma-
tion of mixed disulﬁdes with cysteines on proteins in
vitro and in vivo; a process that is termed protein glu-
tathionylation (Li et al., 2001; Aracena et al., 2003; Tay-
lor et al., 2003). Glutathionylation has been shown to
have profound stimulatory or inhibitory effects on the
functions of several proteins (Barrett et al., 1999; Wang
et al., 2001; Humphries et al., 2002; Aracena et al., 2003;
Caplan et al., 2004), although its role in regulating ABC
transporters is unknown. This covalent modiﬁcation can
be reversed in vitro and in vivo by glutaredoxins (thiol
disulﬁde oxidoreductases), which has led several groups
to propose that glutationylation is a dynamic posttransla-
tional modiﬁcation that can reversibly inﬂuence protein
function during oxidative stress (Huang and Huang,
2002; Lind et al., 2002; Fernandes and Holmgren, 2004).
Finally, the relationship between glutathione and CFTR
is of added interest because of recent reports that (a)
CFTR can transport reduced and oxidized glutathione
in addition to small anions by an unknown mechanism
(Linsdell and Hanrahan, 1998; Kogan et al., 2003) and
(b) GSNO can enhance the biosynthetic maturation of
CFTR processing mutants that associate with cystic ﬁbro-
sis (Zaman et al., 2001). Based on this latter result, Za-
man et al. (2001) proposed that GSNO might be a useful
therapeutic agent for CF. Given this growing interest
in the connections between CFTR and glutathione, it
seemed important to clarify the effects of reactive forms
of glutathione on the most well-accepted property of
CFTR; namely, its chloride channel function.
Here we provide functional and biochemical evi-
dence for the reversible glutathionylation of human
CFTR channels by several oxidized forms of gluta-
thione. Glutathionylated channels exhibit very low
open rates in the presence of normally saturating con-
centrations of ATP, but can be protected from this inhi-
bition if they are ﬁrst locked open with a poorly hydro-
lyzable ATP analogue. We provide evidence that the
major site of inhibition is cys-1344, which is proximal to
the ABC signature sequence in NBD2. Based on our
data and on comparisons to the crystal structures of
other ABC transporters, we propose that glutathionyla-
tion at this site disrupts ATP binding or the link be-
tween ATP binding and pore opening (the preliminary
results of this study were presented in abstract form at
the 2003 Biophysical Society meeting).
 
MATERIALS AND METHODS
 
Cell Culture, DNA Constructs, and Transfections
 
Baby hamster kidney (BHK) cells stably expressing wild-type (WT)
human CFTR (BHK-CFTR) were provided by J. Hanrahan (Mc-
Gill University, Montreal, Quebec, Canada). BHK-CFTR cells and
Calu-3 human airway epithelial cells expressing native CFTR were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Media-
tech) supplemented with 5% or 10% FBS and 1 mM penicillin–
streptomycin. The growth media for the BHK-CFTR cells also con-
tained 0.5 mM methotrexate to maintain selection for CFTR-
expressing cells (Chappe et al., 2003). The S660A/
 
 
 
R-CFTR
mutant and all but one of the alanine-substituted cysteine mutants
were provided by M. Welsh (University of Iowa, Iowa City, IA) (Rich
et al., 1991; Cotton and Welsh, 1997) and were subcloned into the
pCDNA3 expression vector (Invitrogen). C1458A-CFTR was gener- 
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ated by PCR mutagenesis and subcloned into pCDNA3. A CFTR
construct lacking all 18 cysteines (16CS C590L/592L) was provided
by D. Gadsby (Rockefeller University, New York, NY) (Mense et al.,
2004). Cys-1344 was reintroduced into the latter construct by PCR
mutagenesis and both constructs (
 
 
 
/
 
 
 
 cys-1344) were subcloned
into the pIRESneo2 expression vector (CLONTECH Laboratories,
Inc.). All mutations were conﬁrmed by DNA sequencing.
HEK-293T cells were transiently transfected with WT or mu-
tant CFTR cDNA using the Lipofectamine transfection kit follow-
ing manufacturer’s recommendations (Invitrogen). HEK-293T
cells were cultured in DMEM. All cells were grown on plastic cov-
erslips for patch clamp recording and were used 1–4 d post-seed-
ing. HEK-293T cells that were transfected with S660A/
 
 
 
R-CFTR
or with the cys-free constructs were grown overnight at 27
 
 
 
C be-
cause these mutants are temperature-sensitive ER processing mu-
tants as determined by immunoblot analysis.
 
Electrophysiology and Data Analysis
 
Macroscopic and single channel currents were recorded in the
excised, inside-out conﬁguration. Patch pipettes were pulled
from Corning 8161 glass to tip resistances of 1.5–4.0 mOhm
(macroscopic recordings) or 15–18 mOhm (single channel stud-
ies). CFTR channels were activated following patch excision by
exposure of the cytoplasmic face of the patch to catalytic subunit
of PKA (110 U/ml; Promega) and MgATP (1.5 mM). CFTR cur-
rents were recorded in symmetrical solution containing (in mM)
140 
 
N
 
-methyl-
 
d
 
-glucamine-Cl, 3 MgCl
 
2
 
, 1 EGTA, and 10 TES. The
pH was adjusted to 7.3 unless otherwise noted. Macroscopic cur-
rents were evoked using a ramp protocol from 
 
 
 
80 to 
 
 
 
80 mV
with a 10-s time period. Patches were held at 
 
 
 
80 mV for sin-
gle channel recordings. All patch clamp experiments were per-
formed at 21–23
 
 
 
C. Signals from macroscopic and single channel
recording were ﬁltered at 20 and 200 Hz, respectively. Data ac-
quisition and analysis were performed using pCLAMP8 software
(Axon Instruments). Curve ﬁtting for kinetic analysis was per-
formed using Microcal Origin software. Averaged data are pre-
sented as mean 
 
  
 
SEM. Statistical comparisons were made by
performing unpaired 
 
t
 
 tests unless otherwise indicated.
 
Biochemical Detection of CFTR Glutathionylation in 
Microsomal Membrane Vesicles
 
Reduced glutathione (GSH) was labeled with biotin (EZ-Link
Sulfo-NHS-LC-Biotin; Pierce Chemical Co.) by reaction of the
primary amine of GSH with 
 
N
 
-hydroxysulfosuccinimide (NHS)-
biotin. The reaction was performed by adding stoichiometric
amounts (10 mM) of NHS-biotin and GSH to PBS (pH 7.4) for
1 h at 21–23
 
 
 
C. Unreacted NHS-biotin was quenched by the addi-
tion of 50 mM ethanolamine. The isolation of microsomal mem-
brane vesicles from BHK-CFTR cells followed exactly a previously
published protocol (Aleksandrov et al., 2001). Glutathionylation
of CFTR in microsomes was performed by incubating the mi-
crosomes (200 
 
 
 
g) with 100 
 
 
 
M diamide and 125 
 
 
 
M biotin-
GSH for 10 min at 21–23
 
 
 
C in PBS. Some samples were then
treated with 4 
 
 
 
M 
 
E. coli
 
 glutaredoxin (Grx1) (plus 1 mM GSH),
20 mM GSH, or 20 mM dithiothreitol (DTT) for an additional 15
min at 21–23
 
 
 
C. Microsomes were then solubilized in 0.2% Tri-
ton X-100 in PBS, and biotinylated CFTR was mixed with Stepta-
vidin beads (Novagen) in this buffer for 2 h at 21–23
 
 
 
C. Beads
were then pelleted by a brief spin and then washed three times in
1 ml of PBS containing 0.2% Triton X-100. CFTR was eluted in
SDS sample buffer containing 50 mM DTT, resolved by SDS-
PAGE (4–15% polyacrylamide, Bio-Rad Laboratories), trans-
ferred to PVDF membranes, blocked for 1 h at 21–23
 
 
 
C with 5%
milk in Tris (25 mM) buffered saline (TBS), and then incubated
for 1 h with CFTR monoclonal antibody (R&D Systems; 24-1).
Blots were then washed extensively in TBS and incubated with
goat anti-mouse HRP-conjugated antibody (Amersham Biosci-
Figure 1. Reversible inhibition of CFTR channel activity by
GSSG. Macroscopic currents were recorded for membrane
patches excised from BHK-CFTR cells as described in materials
and methods. (A) GSSG was added at the indicated ﬁnal bath
concentrations. The bath chamber was washed free of PKA and
GSSG and then PKA (110 U/ml each addition), and 20 mM DTT
was added as indicated. Glibenclamide (300  M), a voltage-
dependent blocker of CFTR current, was added at the end of
the experiment. (B) Corresponding I–V curves showing voltage-
independent inhibition of CFTR current by GSSG. (C) Modest
effect of GSH on CFTR current. Dotted lines indicate zero current
levels. 
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ences; 1:5,000 dilution) for 1 h. Following extensive washing in
TBS, blots were exposed to SuperSignal West Pico Chemilumi-
nescent Substrate (Pierce Chemical Co.) for 5 min and then de-
veloped on HXR ﬁlm (Hawkins X-Ray Supply) for 0–5 min.
 
Materials
 
GSH, GSSG, 
 
S
 
-nitrosoglutathione (GSNO), and puriﬁed 
 
E
 
. 
 
coli
 
 glu-
taredoxin (Grx1) and thioredoxin were purchased from Calbio-
chem. Recombinant human glutaredoxin1 was purchased from
American Diagnostica Inc. The monothiol mutant of 
 
E. coli
 
 Grx3
(C14S/C65Y) was expressed and puriﬁed as previously described
(Nordstrand et al., 1999). All other reagents were from Sigma-
Aldrich. Glutaredoxins were reconstituted in sterile distilled H
 
2
 
O.
Glibenclamide and 
 
N
 
-ethylmaleimide (NEM) were dissolved and
stored in DMSO. Mixtures of diamide and reduced glutathione
(GSH) and GSNO stocks were made fresh daily in H
 
2
 
O.
 
RESULTS
 
CFTR Channel Activity Is Inhibited by Oxidized 
Forms of Glutathione
 
Fig. 1 shows that glutathione disulﬁde (GSSG) gradu-
ally inhibited macroscopic CFTR current (
 
t
 
1/2
 
 of 5–10
min) when added to the cytosolic face of an inside-out
patch excised from a BHK-CFTR cell. The inhibition by
GSSG was voltage independent (Fig. 1 B) and could be
reversed by adding a high concentration (20 mM) of
the reducing agent DTT (Fig. 1 A; see mean data in
Fig. 2 D). Conversely, reduced glutathione (GSH; 10-20
mM) had only modest effects on macroscopic CFTR
currents (Fig. 1 C). Although it had been reported pre-
viously that GSH blocks the CFTR pore (Linsdell and
Hanrahan, 1998), this blocking effect apparently was
rather weak under the conditions of our experiments.
GSSG promotes the glutathionylation of proteins at
high concentrations such as those required to inhibit
CFTR currents (Aracena et al., 2003). Accordingly, we
tested the effects of two other oxidized forms of glu-
tathione that are more potent thiolating reagents; (1)
GSNO, a naturally occurring form of glutathione that
promotes glutathionylation either directly or via metab-
olites such as GS(O)SG (Li et al., 2001; Huang and
Huang, 2002), and (2) GSH together with diamide, a
strong thiol oxidizer (Fig. 2). Diamide is an exception-
Figure 2. CFTR inhibition
by GSNO and diamide/GSH.
(A) GSNO inhibition of CFTR
currents. PKA inhibitory
peptide (1.4  g/ml PKI) was
added at the ﬁrst arrow. (B)
Reversible inhibition of CFTR
current by equimolar di-
amide/GSH. (C) CFTR chan-
nels are protected from di-
amide/GSH inhibition by
pretreating the patch with
NEM. NEM by itself stimu-
lated the current as previously
reported for CFTR (Cotton
and Welsh, 1997). NEM, PKA,
and PKI (but not MgATP)
were washed out from the
bath where indicated. (D)
Mean data showing the inhib-
itory effects of GSNO (200
 M), GSSG (20 mM), and
diamide/GSH (20  M) on
CFTR current and the rescue
by subsequent addition of
20 mM DTT. Also shown is
the protective effect of NEM
pretreatment (0.1 mM) on
the inhibition by diamide/
GSH (20  M). The results
shown in Fig. 1 D were ob-
tained following PKA inhibi-
tion with PKI (1.4  g/ml). All
data are normalized to the
current recorded before the
addition of the glutathione
species. The number of ex-
periments is shown above
each bar. 
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ally potent oxidizer of GSH (Kosower and Kosower,
1995), and mixtures of diamide and GSH (diamide/
GSH) have been reported to be effective glutathionylat-
ing reagents (Humphries et al., 2002). To rule out a triv-
ial effect of oxidized forms of glutathione on the PKA in
the bath, these experiments were performed following
PKA inhibition with excess inhibitory peptide (PKI; 1.4
 
 
 
g/ml). Inactivating the PKA inhibited the current
by 
 
 
 
50% presumably because of phosphatase activity
within the membrane patch (Fig. 2, A–C). The subse-
quent addition of GSNO nearly abolished the CFTR
currents but with a faster time course and at much lower
concentrations than observed for GSSG (50–200 
 
 
 
M;
see Fig. 2 A for time course and Fig. 2 D for mean data).
The inhibition by GSNO was reversed by the addition of
DTT (20 mM). The effect of GSNO was unlikely due to
NO that had been released from GSNO since the addi-
tion of 2 mM SNAP (an NO donor) had no effect on
the CFTR current (unpublished data).
CFTR currents also were rapidly inhibited by equimo-
lar diamide/GSH at very low concentrations (5–20 
 
 
 
M;
Fig. 2, B and D). The combination of diamide and
GSH, when premixed for 2–5 min, had the most potent
effects on CFTR channel activity of the various forms of
glutathione that were tested. Diamide alone, which can
promote disulﬁde bond formation in proteins, had no
effects at these low concentrations. In addition, CFTR
currents were not inhibited by adding GSH alone to
patches that had been pretreated with diamide (unpub-
lished data). Thus, the key reaction in the diamide/
GSH mixture is oxidation by glutathione. As with GSSG
and GSNO, the inhibition of CFTR currents by GSNO
or diamide/GSH was voltage independent and com-
pletely reversible by DTT. The inhibition by diamide/
GSH also could be blunted by prior incubation with 0.1
mM NEM (a thiol alkylating agent; Fig. 2, C and D),
which by itself moderately stimulates CFTR current as
reported previously (Cotton and Welsh, 1997).
The protection by NEM and the rescue by DTT indi-
cate that reactive forms of glutathione inhibit CFTR
currents by oxidizing a cysteine or cysteines on the
CFTR polypeptide. If so, this inhibition should be sensi-
tive to ambient pH since the thiolate form of cysteine
typically is the preferred target for oxidation (Grifﬁth
et al., 2002). Fig. 3 shows that the inhibitory effect of di-
amide/GSH on CFTR currents was blunted at low pH
(6.3) and was accelerated at high pH (8.3). This pH de-
pendence is consistent with oxidation of a titratable cys-
teine by reactive forms of glutathione possibly by a glu-
tathionylation mechanism.
 
Glutaredoxin Rescues CFTR Channels from Inhibition by 
Oxidized Forms of Glutathione
 
If reactive forms of glutathione inhibit CFTR currents
by a glutathionylation mechanism, then this effect
should be reversed by an enzyme with reductase activ-
ity toward mixed disulﬁdes. To explore this point, we
tested two enzymes (thioredoxin [Trx] and glutare-
doxin [Grx]) for their abilities to rescue CFTR cur-
rents from inhibition by oxidized glutathione. These
enzymes have overlapping speciﬁcities but have dif-
ferent preferences for mixed disulﬁdes (i.e., Grx has
greater activity as a mixed disulﬁde reductase pro-
vided that GSH is present as a cofactor, or electron
Figure 3. pH dependence of the inhibition of CFTR current
by diamide/GSH. Macroscopic currents were recorded for
membrane patches excised from BHK-CFTR cells at pH 7.3 (A),
pH 6.3 (B), and pH 8.3 (C). Diamide and GSH were premixed at
pH 7.3 and then added to the bath where indicated. Results are
representative of four experiments. CFTR currents per se were
only modestly affected by changing the pH over this range;
e.g., changing the bath pH from 7.3 to 8.3 resulted in a 10–20%
inhibition of macroscopic current (unpublished data). 
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donor; Fernandes and Holmgren, 2004). Recombi-
nant 
 
E. coli
 
 Grx1 at a concentration of 4 
 
 
 
M restored
the CFTR currents following inhibition with diamide/
GSH to 
 
 
 
50% of control (prediamide/GSH) levels
(Fig. 4 A; see also Fig. 4 D for Grx effects on channels
inhibited by GSNO and GSSG). Similar results were
obtained for puriﬁed human Grx1 (unpublished data).
Conversely, Trx was unable to rescue CFTR channels
that had been inhibited by diamide/GSH when
added either before or after washout of the diamide
and GSH (Fig. 4 B). Grx required GSH (1 mM) as an
electron donor to rescue the CFTR currents (un-
published data). At these low concentrations, GSH
by itself had negligible effects on CFTR currents.
However, at much higher concentrations (
 
 
 
10 mM),
GSH alone could slowly recover the currents follow-
ing prior inhibition with diamide/GSH, GSNO, or
GSSG presumably because of its antioxidant activity
(Fig. 4 D).
Grx has two cysteines in its active site that enable it
to reduce intramolecular disulﬁde bonds by a dith-
iol mechanism as well as to reduce mixed disulﬁdes
by a monothiol mechanism (Bushweller et al., 1992;
Fernandes and Holmgren, 2004). To distinguish be-
tween these two possible mechanisms by which Grx
could rescue oxidized CFTR channels, we also tested
a Grx mutant that lacks the second cysteine in the ac-
tive site (
 
E. coli
 
 Grx3 C14S/C65Y). This Grx mutant
is a highly speciﬁc mixed disulﬁde reductase that
lacks protein disulﬁde reductase activity (Bushweller
et al., 1992; Fernandes and Holmgren, 2004). Fig. 4 C
shows that the Grx mutant also rescued CFTR cur-
rents from prior inhibition by diamide/GSH, which
supports the idea that reactive forms of glutathione
inhibit CFTR channels by a glutathionylation mecha-
nism. Like for the WT enzyme, the current recovery
was substantial but incomplete. The incomplete re-
covery by Grx may indicate that reactive glutathione
species also inhibit channel function by an additional
mechanism that does not involve glutathionylation.
In this regard, we show below that Grx completely re-
verses the inhibition by diamide/GSH of a mutant
CFTR channel that lacks most of the R domain (see
Fig. 9).
Figure 4. Glutaredoxin
rescues CFTR channels from
inhibition by reactive glu-
tathione species. (A) Puriﬁed
E. coli Grx1 (4 and 8  M)
reversed the inhibition of
CFTR activity induced by di-
amide/GSH in an excised
BHK-CFTR patch. (B) Puri-
ﬁed E. coli Trx was unable to
rescue CFTR activity follow-
ing the addition of diamide/
GSH. (C) CFTR activity also
was rescued by a mutant Grx
that is a speciﬁc mixed disul-
ﬁde reductase (Grx3 C14S/
C65Y). (D) Mean data show-
ing the inhibitory effects of
the indicated glutathione
species (20  M diamide/
GSH; 200  M GSNO; 20 mM
GSSG) and the rescue effects
of  E. coli Grx1 (4  M Grx1
plus 1 mM GSH) and GSH
alone at high dose (20 mM).
CFTR channels were preacti-
vated with PKA and MgATP as
described in materials and
methods, and all additions
were made after inhibiting
the bath PKA with excess PKI
inhibitory peptide (1.4  g/
ml). Results are normalized
to the CFTR currents re-
corded before addition of the
reactive glutathione species.
The number of experiments is shown above each bar. For each glutathione species, the rescue by Grx or high GSH was statistically
signiﬁcant (P   0.05) when compared with the current before Grx or GSH addition. 
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Biochemical Conﬁrmation of Reversible CFTR 
Glutathionylation
 
As a biochemical test for CFTR glutathionylation under
these conditions, microsomes containing CFTR chan-
nels were incubated with biotinylated glutathione (bi-
otin-GSH) with or without diamide at concentrations
that inhibit CFTR channel activity. Microsomes were
then solubilized and biotinylated proteins were cap-
tured on streptavidin beads followed by immunoblot-
ting with a CFTR antibody. Fig. 5 shows that CFTR
channels were modiﬁed by biotin-GSH (i.e., captured
on streptavidin beads) following treatment with di-
amide and biotin-GSH together but not with either
alone. In addition, this modiﬁcation could be reversed
by the same factors that rescued CFTR currents from
inhibition by oxidized forms of glutathione; namely,
Grx (with 1 mM GSH as a cofactor), DTT, and high
concentrations of GSH alone. These biochemical re-
sults conﬁrm that membrane-associated CFTR polypep-
tides can be reversibly glutathionylated under the same
conditions that promote channel inhibition.
 
Glutathionylation Virtually Abolishes the Opening of 
Individual CFTR Channels
 
The nearly complete inhibition of macroscopic CFTR
currents by oxidized glutathione implies that glutathi-
onylation dramatically affects the gating of CFTR chan-
nels. To examine this point, we performed single chan-
nel experiments to assess the effect of thiolation on the
gating properties of individual CFTR channels in ex-
cised inside-out patches (Fig. 6). Calu-3 airway epithe-
lial cells were used for these experiments, since the lev-
els of native CFTR protein in these cells (at least 5–10-
fold lower than for recombinant CFTR in BHK-CFTR
cells) are optimal for obtaining patches with one or a
few detectable channels. In pilot experiments, we veri-
ﬁed that macroscopic CFTR currents in patches ex-
cised from Calu-3 cells were reversibly inhibited by di-
amide/GSH as in BHK-CFTR patches (Fig. 6 A). In
single channel experiments, we observed a nearly com-
plete inhibition of open probability (P
 
o
 
) that was due
primarily to a dramatic reduction in the frequency of
channel openings (Fig. 6, B–D). This marked inhibi-
tion of channel opening rate was observed in the pres-
ence of a normally maximally activating concentration
of MgATP (1.5 mM). Increasing the MgATP concentra-
tion up to 10 mM had no stimulatory effect on the
activities of glutathionylated CFTR channels (unpub-
lished data). However, channels that were silenced by
glutathionylation could be stimulated by the subse-
quent addition of Grx and GSH. These results indicate
that glutathionylation of CFTR reversibly inhibits chan-
nel opening in the presence of a normally saturating
concentration of MgATP.
 
Cys-1344 Is the Major Site of CFTR Channel Inhibition by 
Oxidized Forms of Glutathione
 
The simplest explanation of our functional and bio-
chemical results is that reactive glutathione species
inhibit CFTR channel gating by modifying a cysteine
residue in the CFTR polypeptide. To identify cysteine
residues in CFTR channels that may be targets for
glutathionylation, we screened a panel of alanine-sub-
stituted cysteine mutants for inhibition by oxidized
forms of glutathione (Fig. 7). Each mutant (as well as
WT-CFTR) was transfected into HEK-293T cells and
tested for inhibition by diamide/GSH, GSNO, or GSSG
in excised membrane patches. All CFTR constructs,
with the exception of C1344A-CFTR, were markedly in-
hibited by diamide/GSH (Fig. 7, B and C). C1344A-
CFTR was largely, although not completely, resistant to
each of the three glutathione species at the indicated
concentrations (Fig. 7, B and D). The fact that this
mutant is not completely protected may indicate that
other cysteines can be modiﬁed by oxidized glu-
tathione, but that such modiﬁcations have less dra-
matic effects on channel function than modiﬁcation at
cys-1344.
To determine if cys-1344 alone is sufﬁcient for CFTR
inhibition by reactive glutathione species, we tested the
effects of diamide/GSH on two additional constructs:
Figure 5. Reversible glutathionylation of CFTR in isolated
membrane vesicles. Microsomal membranes were prepared from
BHK-CFTR cells as described in materials and methods. Mi-
crosomes (200 mg total protein) were incubated in PBS in the
absence (lane 1) or presence of 125  M biotin GSH and/or
100  M diamide for 10 min at 21–23 C (lanes 2–7). Where indi-
cated, 4  M E. coli Grx1 (plus 1 mM GSH) (lane 5), 20 mM GSH
(lane 6), or 20 mM DTT (lane 7) was added for an additional
15 min at 21–23 C. Microsomes were then solubilized, and biotin-
containing proteins were isolated by pull-down with streptavidin-
agarose and probed for CFTR by immunoblotting as described in
materials and methods. Total CFTR protein was assayed by
immunoprecipitating CFTR from 3% of the total crude membrane
lysate and blotting the immunoprecipitate with the same CFTR
monoclonal antibody. This experiment was repeated four times
with similar results. 
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(1) a CFTR construct that lacks all cysteine residues
(16CS C540L/C542L; Mense et al., 2004) and (2) a
CFTR construct that contains cys-1344 as its only cys-
teine (cys-1344-only). We were able to obtain a limited
amount of patch clamp data for each (Fig. 8), although
these constructs are severe ER processing mutants that
express poorly in mammalian cells (not depicted). Cys-
free CFTR channels were insensitive to diamide/GSH
(Fig. 8, A and C), which conﬁrms that channel inhibi-
tion is due to oxidation of a CFTR cysteine. The cys-
1344-only construct was inhibited 
 
 
 
60% by a dose of
diamide/GSH that caused an 80–90% decrease in
WT currents (compare Fig. 8 C, Fig. 2 D, and Fig. 7
C). Thus, oxidation of cys-1344 alone can account for
much of the inhibition by diamide/GSH. The lack of
complete recovery of the inhibition by diamide/GSH
might reﬂect the involvement of other cysteines in the
inhibitory response (see above). Alternatively, the cys-
1344-only construct may be less sensitive to diamide/
GSH than the WT channel because of altered struc-
tural and/or functional properties (evidenced by its in-
efﬁcient biosynthetic processing).
Cys-1344 is located near the signature sequence in
NBD2 (Fig. 7 A). The signature sequences in other
ABC transporters have been shown to participate in
NBD dimerization and ATP binding as well as to associ-
ate closely with structural elements that link the NBDs
to the transmembrane domains (Locher et al., 2002;
Chen et al., 2003). The local sequence surrounding cys-
1344 lacks basic residues that might otherwise favor the
thiolate form of this cysteine (i.e., the form that is the
presumed substrate for oxidation). However, by mass
spectrometry, we veriﬁed that a synthetic peptide con-
taining cys-1344 (a.a. 1340–1352) could be glutathion-
ylated at this position when incubated with 20 mM
GSSG for 30 min at 22
 
 
 
C (pH 7.4; unpublished data).
We could not purify enough full-length CFTR protein
for similar analysis by mass spectrometry. In addition,
Figure 6. Glutathionylated CFTR channels
exhibit markedly reduced open rates. (A) Macro-
scopic current trace showing inhibition of CFTR
current by diamide/GSH in membrane patch
excised from Calu-3 epithelial cell. PKI (1.4  g/
ml) was added at the arrow. (B) Single channel
record obtained from Calu-3 patch showing
marked inhibition of channel opening by di-
amide/GSH (20  M) and partial recovery by E.
coli Grx1 (4  M Grx1 plus 1 mM GSH). Holding
potential was  80 mV. (C) Mean data showing
inhibitory effects of diamide/GSH (20  M) and
rescue effects of Grx1 ( 1 mM GSH) on single
channel open probability (Po) and channel
opening rate (n   3 patches). The results shown
in B and C were obtained without PKI addition.
Nearly identical results were obtained for two
additional patches that were treated with diamide/
GSH after PKI addition (unpublished data).135 Wang et al.
structural elements from other regions of the polypep-
tide may inﬂuence the susceptibility of this residue to
oxidation (see below and discussion).
CFTR Channels That Are First “Locked Open” 
by a Poorly Hydrolyzable ATP Analogue Are Protected 
from Inhibition by Glutathionylation
The major cytoplasmic domains that control CFTR
channel gating are the NBDs and the R domain. If glu-
tathionylation occurs at a site near one of the ATP
binding pockets in an NBD rather than near one of the
phosphorylation sites in the R domain, one would pre-
dict that (a) an R domain deletion mutant that does
not require PKA phosphorylation for channel activa-
tion would also be inhibited by glutathionylation, and
(b) channels that are locked upon with a poorly hydro-
lyzable ATP analogue (AMP-PNP) that binds stably
to the channel would be protected from this inhibi-
tion. Regarding the latter prediction, the signature se-
quences of Rad50 are buried in the AMP-PNP–bound
form of this ATPase (Hopfner et al., 2000). Fig. 9 (A
and B) shows that S660A/ R-CFTR, which was previ-
ously shown to have moderate channel activity in the
absence of PKA (Rich et al., 1991), was substantially
and reversibly inhibited by diamide/GSH in the ab-
sence of added kinase. This result argues against a pri-
mary effect of thiolation on CFTR phosphorylation. In-
terestingly, Grx could rescue completely the currents
mediated by S660A/ R-CFTR, which indicates that the
Grx-insensitive oxidation previously observed for the
WT channel (Fig. 4) requires an intact R domain. Fig. 9
(C and D) shows that the rate of channel inhibition by
diamide/GSH was slowed  10-fold in the presence of
AMP-PNP. This poorly hydrolyzable analogue greatly
prolongs CFTR channel openings apparently by stably
binding to one or both NBDs (Gunderson and Kopito,
1994; Aleksandrov et al., 2001). The time constant for
current inhibition in the presence of AMP-PNP (ca.
250 s) is similar to the “off rate” for AMP-PNP observed
in previous washout or deactivation experiments (Powe
et al., 2002). We interpret the AMP-PNP results to indi-
cate that open channels are protected from inhibition
by thiolation. The gradual inhibition that is observed in
the presence of AMP-PNP likely reﬂects the modiﬁca-
tion of channels that have closed at a very slow rate due
to the slow dissociation and/or hydrolysis of AMP-PNP.
Figure 7. CFTR channels
that lack cys-1344 (C1344A-
CFTR) are largely resistant
to inhibition by reactive glu-
tathione species. (A) Sche-
matic view of CFTR depicting
the 18 cysteines within the
polypeptide and the speciﬁc
location of cys-1344 near
the  ABC signature motif in
NBD2. Bottom, sequences
surrounding the NBD2 sig-
nature sequences in CFTR
from human (h), mouse (m),
and shark(s). (B) Mean data
showing the inhibitory effects
of diamide/GSH (20  M) on
the indicated alanine-substi-
tuted mutants and WT CFTR
expressed in HEK-293T cells.
Quad mutant is C128/225/
343/866. Diamide/GSH was
added after inhibiting the
bath PKA with PKI. Data
are normalized to currents
measured just before the
addition of diamide/GSH.
(C) Representative current
trace showing resistance of
C1344A-CFTR to inhibition by
diamide/GSH. (D) Mean data
comparing the sensitivities of
WT CFTR and C1344A-CFTR
to inhibition by diamide/
GSH (20  M), GSNO (200
 M), and GSSG (20 mM).136 Reversible Thiolation of CFTR
This protective effect of the poorly hydrolyzable AMP-
PNP is consistent with modiﬁcation at cys-1344, since
the signature sequence in NBD2 likely is occluded in
the nucleotide-bound state of the channel (see sche-
matic in Fig. 10).
DISCUSSION
The present results indicate that human CFTR chan-
nels are reversibly inhibited by several reactive forms of
glutathione. The underlying mechanism appears to in-
volve the glutathionylation of cys-1344 near the signa-
ture sequence in NBD2. Inhibited CFTR channels ex-
hibit very low open rates, but can be rescued by several
glutaredoxins, including a mutant form that is a selec-
tive mixed disulﬁde reductase. This, coupled with bio-
chemical evidence for the reversible glutathionylation
of CFTR protein in microsomes, supports the argu-
ment that channel activity is inhibited by glutathionyla-
tion of a cysteine or cysteines within the CFTR polypep-
tide. We were unable to directly detect the glutathion-
ylation of cys-1344 within the intact CFTR protein due
to technical reasons. However, the fact that C1344A-CFTR
was the only cysteine mutant that was highly resistant
to inhibition by all three reactive glutathione species
(GSNO, GSSG, and diamide/GSH) indicates that this
cysteine likely is the functionally important site for glu-
tathionylation. To our knowledge, this is the ﬁrst evi-
dence for the modulation of an ABC transporter by glu-
tathionylation. The present ﬁndings provide insights
into the structural basis of CFTR channel gating by sup-
porting an important role of NBD2 (in particular, the
region surrounding cys-1344) in controlling the open-
ing of CFTR channels. Our results also raise the possi-
bility that glutathionylation at this site may reversibly
silence CFTR channels under strongly oxidizing condi-
tions (e.g., in inﬂamed lung or gut). These implica-
tions are discussed in more detail below.
How Does CFTR Glutathionylation Disrupt Channel Gating?
CFTR channel opening is controlled primarily by two
factors: MgATP binding to both NBDs and phosphory-
lation of the R domain (Gadsby and Nairn, 1999). Two
observations rule out the possibility that the markedly
reduced open rate of the glutathionylated CFTR chan-
nel is due to altered phosphorylation. First, CFTR
channels could be inhibited by glutathionylation and
subsequently rescued by Grx or DTT after PKA inhibi-
tion or removal. Second, an R domain deletion con-
struct that does not require phosphorylation for its ac-
tivity also was inhibited by glutathionylation. These
results point to an effect of glutathionylation on nucle-
otide binding or a downstream event that couples ATP
binding to channel opening.
The location of the apparent site of modiﬁcation
(cys-1344) near the signature sequence in NBD2 is con-
Figure 8. Cys-1344 is sufﬁcient for reactive glutathione species to
inhibit CFTR currents. Cys-free CFTR and cys-1344-only CFTR were
expressed in HEK-293T cells as described in the text. (A) Repre-
sentative current trace showing lack of inhibition of cys-free CFTR
by diamide/GSH. To conﬁrm that the observed currents were
CFTR-mediated, PKA and MgATP were washed out of the bath and
1.5 mM MgATP was readded where indicated. (B) Representative
current trace showing inhibition of the current mediated by the
cys-1344-only construct by diamide/GSH. The currents mediated
by both constructs were blocked by glibenclamide in a voltage-
dependent manner, although they were inhibited by PKI to a
smaller degree than that observed for WT channels (possibly because
of the altered conformations of these ER processing mutants). (C)
Mean data showing percent current remaining after the addition
of 20  M diamide/GSH (cys-free, n   7; cys-1344-only, n   8).137 Wang et al.
sistent with an effect of glutathionylation on ATP-
dependent channel opening. Current structural mod-
els of other ABC transporters (e.g., the bacterial BtuCD
and maltose transporters) place their signature se-
quences at an interface between the two NBDs, which
associate as dimers in these transporters (Locher et al.,
2002; Chen et al., 2003). The signature sequence of
one NBD opposes the Walker A motif (or P loop) of
the other NBD to form a composite nucleotide binding
pocket. Residues within each of these sequences or mo-
tifs interact directly with ATP (Fig. 10, A and B). It is
likely that some or all of the basic elements of this
model apply to the CFTR NBDs as well. Although there
is little structural or physical evidence for dimerization
of the CFTR NBDs (due perhaps to technical reasons),
there is considerable functional evidence for coopera-
tive interactions between the two CFTR NBDs regard-
ing both channel gating and nucleotide binding/hy-
drolysis (e.g., Ramjeesingh et al., 1999; Powe et al.,
2002; Vergani et al., 2003; Kidd et al., 2004). And, there
is good evidence that the signature sequences of the
two CFTR NBDs play important roles in channel gat-
ing. For example, disease-associated mutations within
the NBD1 signature sequence (e.g., G551D) dramati-
cally inhibit the rate of CFTR channel opening (Li et
al., 1996). In addition, Cotton and Welsh (1998) re-
ported that introducing an engineered cysteine into
the signature sequence of NBD2 sensitized CFTR chan-
nels to inhibition by NEM. The apparent location of
glutathionylation to cys-1344 is consistent with the ob-
servation that CFTR channels that are ﬁrst locked open
with the poorly hydrolyzable AMP-PNP are protected
from inhibition. AMP-PNP locks open CFTR channels
by stably associating with one or both NBDs (Gunder-
son and Kopito, 1994; Aleksandrov et al., 2001), which,
according to the structural models described above,
would be expected to occlude residues within and near
the signature sequences.
Given these considerations, it is perhaps not surpris-
ing that the glutathionylation of a cysteine near one of
Figure 9. An R domain
deletion mutant is highly
sensitive to diamide/GSH
inhibition, whereas channels
that are locked open by AMP-
PNP are protected. (A) Inhibi-
tory effect of 20  M diamide/
GSH on macroscopic current
mediated by  R-S660A-CFTR
in patch excised from trans-
fected HEK-293T cell. (B)
Mean data for  R-S660A-
CFTR showing inhibition by
diamide/GSH (20  M) and
recovery by E. coli Grx1 (4
 M) plus 1 mM GSH. Cur-
rents are normalized to
control currents before di-
amide/GSH. Currents were
activated with 1.5 mM MgATP
in the absence of PKA for the
experiments summarized in
A and B. (C) Slow inhibition
of CFTR currents by diamide/
GSH following addition of 2
mM AMP-PNP to BHK-CFTR
patch. Inset, exponential ﬁt
of current trace following
addition of diamide/GSH to
this patch. (D) Mean data
comparing the exponential
time constants for current
inhibition by 20  M diamide/
GSH in the presence and
absence of 2 mM AMP-PNP.
Note that the time constants
in the absence of AMP-PNP
are overestimates due to the
very rapid inhibition observed
under the control condition.138 Reversible Thiolation of CFTR
the signature sequences could disrupt ATP-dependent
channel opening. However, it should be emphasized
that the cysteine at this position (cys-1344) is not essen-
tial for CFTR channel activity per se. CFTR mutants
that lack this residue exhibit robust channel activity
(Fig. 7), and the apparent modiﬁcation of cys-1344 by
NEM (which protects against modiﬁcation of this site)
only modestly affects the channel activity of WT CFTR.
Furthermore, this cysteine is poorly conserved among
CFTR polypeptides across species or among other ABC
transporters (Fig. 7 A). Based on these observations, it
seems likely that glutathionylation at this site affects
channel gating because of the bulk and/or hydrophi-
licity of the covalently linked adduct (i.e., glutathi-
one tripeptide). Such a substantial modiﬁcation could
have large effects on the local structure of the CFTR
polypeptide within the vicinity of the NBD2 signature
sequence.
This putative structural perturbation in NBD2 could
inhibit the opening of CFTR channels in one of two
ways: (1) by reducing the afﬁnity of the NBDs for
MgATP or (2) by disrupting the link between ATP
binding at the NBDs and subsequent pore opening.
The ﬁrst possibility is worth considering given the ap-
parent roles of the signature sequences of ABC trans-
porters in ATP binding, as discussed above. Indeed,
within the crystal structure of the ATP-bound MalK
dimer of the bacterial maltose transporter (Chen et al.,
2003), the residue that corresponds in position to cys-
1344 of CFTR (K132 in E. coli MalK) makes direct con-
tact with the adenine of the bound ATP (Fig. 10 B).
Given this comparison, it seems possible that the glu-
tathionylated CFTR channel would have a lower afﬁnity
for ATP especially with respect to nucleotide binding to
the Walker A motif in NBD1 (which would oppose the
NBD2 signature sequence in current models). How-
ever, there are several arguments against a primary ef-
fect of CFTR glutathionylation on ATP binding. First,
we could not stimulate the low activity of glutathion-
ylated CFTR channels by elevating the bath MgATP
to concentrations above those that normally saturate
CFTR (i.e., from 1.5 to 10 mM; unpublished data).
Thus, if the primary effect of glutathionylation is to re-
duce the afﬁnity for MgATP, then this effect must be
sufﬁciently great to prevent a detectable increase in
channel activity in response to a greater than sixfold in-
crease in MgATP concentration. Second, the binding
interaction with ATP is dominated by the highly con-
served Walker A motifs and signature sequences that
are found in all ABC transporters (Fig. 10, A and B).
The region proximal to the signature sequence that in-
cludes cys-1344 in CFTR is not well conserved among
ABC transporters. This lack of conservation of primary
sequence would seem to be more consistent with a role
for this region as a linker or “relay” rather than in nu-
cleotide binding per se.
On the basis of the latter considerations and the ar-
guments below we favor the second possible mecha-
nism, i.e., disruption of the link between ATP binding
and pore opening in the glutathionylated channel. The
region proximal to the signature sequence of the nu-
cleotide-free form of the bacterial vitamin B12 trans-
porter (BtuCD) lies adjacent to the Q loop, which is
the major structural element linking the NBDs to the
transmembrane domains (Locher et al., 2002). Al-
though currently there is no crystal structure of the
ATP-bound form of a complete ABC transporter, Chen
et al. (2003) have generated a structural model of the
ATP-bound form of the bacterial maltose transporter in
which the region proximal to the signature motif (cor-
responding to the location of cys-1344) similarly is posi-
tioned close to the Q loops. Thus, the residues in the
region proximal to the signature sequence seem to be
well positioned both to sense the binding of ATP and to
relay this information to downstream elements (e.g., Q
Figure 10. Schematic views of the regions proximal to the
signature sequences in related ABC transporters. (A) Schematic
view of ATP binding pockets sandwiched between NBD dimers
based on structures of Rad50 (Hopfner et al., 2000) and MalK
(Chen et al., 2003). (B) ATP binding pocket in the MalK dimer of
the bacterial maltose transporter (adapted from Chen et al.,
2003). Asterisks denote the positions corresponding to cys-1344 in
CFTR NBD2.139 Wang et al.
loops) that presumably mediate channel opening. That
the putative Q loops in CFTR participate in channel
gating is supported by the observations of Berger et al.
(2002), who reported that mutations within the region
of CFTR NBD2 that corresponds to the Q loop of
BtuCD disrupt channel gating. Glutathionylation of
cys-1344 within CFTR could perturb the ability of this
residue and neighboring residues to interact with the
bound ATP (i.e., to sense ATP binding) and/or to in-
teract with the Q loops. This hypothetical mechanism is
consistent with our functional data and with the avail-
able structural data for other ABC transporters as
noted above. However, without additional biochemical
data we cannot completely rule out other possible
mechanisms such as reduced ATP binding (see above)
and/or inhibitory effects of glutathionylation on NBD
dimerization.
Physiologic Implications
The CFTR channel is expressed in lung and gut; tissues
that are continually exposed to thiol oxidizers under a
variety of inﬂammatory conditions (e.g., asthma and
colitis; Montuschi and Barnes, 2002; Pavlick et al.,
2002). Reactive glutathione species are formed during
inﬂammation, some of which have the potential to
glutathionylate target proteins within these tissues.
Although intracellular levels of glutathione disulﬁde
(GSSG) increase in inﬂamed tissues (Sido et al., 1998),
this form of glutathione is not a particularly potent me-
diator of protein glutathionylation (e.g., Fig. 1) and
probably would have little or no effect on CFTR glu-
tathionylation in vivo. However, other more reactive
forms of glutathione (e.g., GSNO or GS(O)SG) can
be produced during inﬂammation, some of which
have  the potential to glutathionylate CFTR channels
(Huang and Huang, 2002). CFTR channels are pro-
tected to a large extent by the actions of GSH and glu-
taredoxin; this was one of the ﬁndings of the present
study. Presumably these factors help prevent inhibition
of CFTR channel activity by weak oxidizers or during
short term exposure to oxidants. In this regard, the
acute treatment of intact Calu-3 epithelial monolayers
with H2O2 reportedly increases rather than decreases
cAMP-dependent anion secretion (Cowley and Lins-
dell, 2002). However, it is possible that the protective
effects of Grx and GSH are overwhelmed under highly
oxidizing conditions and/or during chronic exposure
to oxidants. Human Grx1 itself can be inhibited by oxi-
dation (Starke et al., 1997) such that its protective ef-
fects may become limiting during chronic exposure to
strong oxidants. Further studies will be required to de-
termine the extent to which CFTR channels are modu-
lated by glutathionylation in vivo (e.g., using animal
models of inﬂammation). This is a potentially signiﬁ-
cant issue, since the silencing of CFTR channels by glu-
tathionylation could inﬂuence the physiology of the
inﬂamed lung or gut (e.g., by minimizing CFTR-medi-
ated ﬂuid secretion as a mechanism to counteract di-
arrhea in colitis).
The present ﬁndings have additional implications
with respect to the recent interest in glutathione spe-
cies as modulators of CFTR biogenesis and as trans-
ported substrates of CFTR. Our observation that GSNO
(or one of its metabolites) can inhibit CFTR activity
raises a note of caution about using this glutathione
species to treat CF patients (Zaman et al., 2001). On
the positive side, the concentrations of GSNO that re-
portedly are effective in promoting the biogenesis of
mutant CFTR are quite low and may be below those
GSNO concentrations that would lead to appreciable
CFTR glutathionylation. Regarding the intriguing pos-
sibility that CFTR may itself transport various forms of
glutathione out of cells (Kogan et al., 2003), it would
seem important to determine the extent to which glu-
tathionylation inﬂuences this putative functional at-
tribute of CFTR. Perhaps oxidized forms of glutathione
inhibit GSH export by CFTR as a negative feedback
mechanism to preserve the reducing environment of
the epithelial cell cytoplasm.
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